Riskpilot← Back to searchSign inGet full accessFYSIOMAS AS
ASActiveOrg 919268247Storehagen 2, 6800 FørdeOther human health activities n.e.c. · NACE 8699Est. 20172 employees
Revenue 2024
NOK 774K
-11% vs 2023
EBITDA margin
-2.2%
-127% vs 2023
Equity ratio
-96.8%
Financial strength
Net profit 2024
NOK -19K
-134% vs 2023
| Revenue | NOK 774K | -11% |
| EBITDA | NOK -17K | -127% |
| Net profit | NOK -19K | -134% |
| Total assets | NOK 109K | -28% |
| Equity | NOK -105K | -21% |
| Employees | 2 | — |
Legal name
FYSIOMAS AS
Org number
919268247
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
21. september 2017
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Selskapet skal drive massasje og rehabilitering, samt alt som naturlig står i forbindelse med dette, derunder investeringer og deltagelse i andre selskaper
Address
Storehagen 2, 6800 Førde
Phone
+4747605891
Email
pawlusb@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 926 | 825 | 631 | 651 | 614 | 866 | 774 |
| Staff expenses | −0 | −572 | −401 | −384 | −428 | −526 | −524 | −502 |
| EBITDA | −6 | 37 | 87 | −39 | −44 | −182 | 61 | −17 |
| Depreciation & amort. | −0 | −0 | −0 | −6 | −5 | −4 | −3 | −2 |
| EBIT | −6 | 37 | 87 | −45 | −49 | −186 | 58 | −19 |
| Net financials | 0 | 0 | −0 | −0 | −2 | −0 | 0 | 0 |
| Profit before tax | −6 | 37 | 87 | −45 | −51 | −186 | 58 | −19 |
| Tax | −0 | −0 | 18 | −0 | −15 | −0 | 3 | −1 |
| Net profit | −6 | 37 | 70 | −45 | −36 | −186 | 56 | −19 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 24 | 116 | 161 | 258 | 288 | 28 | 152 | 109 |
| Equity | 24 | 62 | 124 | 79 | 43 | −142 | −87 | −105 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 54 | 37 | 178 | 245 | 170 | 236 | 212 |
| Total debt | 0 | 54 | 37 | 178 | 245 | 170 | 239 | 214 |
EBITDA margin
-2.2%
This company
15.8%
Market median
-114% vs market
20172024
Equity ratio
-96.8%
This company
38.2%
Market median
-353% vs market
20172024
Return on equity
-1864800.0%
This company
18.4%
Market median
-10134883% vs market
20172024
Net profit margin
-2.4%
This company
8.1%
Market median
-130% vs market
20172024
Asset turnover
7.10×
This company
1.12×
Market median
+534% vs market
20172024
Debt / equity
2.03×
This company
0.62×
Market median
-227% vs market
20172024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FYSIOMAS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pawel Borowinski | Chairman | 0 companies |
| Lars Gaute Terum | Board of Directors | 0 companies |